These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26523670)

  • 21. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aflibercept for the treatment of diabetic macular edema.
    Harkins KA; Haschke M; Do DV
    Immunotherapy; 2016 May; 8(5):503-10. PubMed ID: 26907516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current trends in the pharmacotherapy of diabetic retinopathy.
    Kumar B; Gupta SK; Saxena R; Srivastava S
    J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and Emerging Treatment for Diabetic Macular Edema.
    Ung C; Borkar DS; Young LH
    Int Ophthalmol Clin; 2017; 57(4):165-177. PubMed ID: 28885255
    [No Abstract]   [Full Text] [Related]  

  • 26. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
    Ajlan RS; Silva PS; Sun JK
    Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of aflibercept in the management of diabetic macular edema.
    Chang AA; Hong T; Ewe SY; Bahrami B; Broadhead GK
    Drug Des Devel Ther; 2015; 9():4389-96. PubMed ID: 26273198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching Anti-VEGF Drugs in the Treatment of Diabetic Macular Edema.
    Banaee T; Ashraf M; Conti FF; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2017 Sep; 48(9):748-754. PubMed ID: 28902336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging corticosteroid delivery platforms for treatment of diabetic macular edema.
    Shah J; Vaze A; Tang Lee Say T; Gillies MC; Fraser-Bell S
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):383-394. PubMed ID: 32815413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Macular Edema: Options for Adjunct Therapy.
    Calvo P; Abadia B; Ferreras A; Ruiz-Moreno O; Verdes G; Pablo LE
    Drugs; 2015 Sep; 75(13):1461-9. PubMed ID: 26242766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for anti-VEGF treatment of diabetic macular edema.
    Bandello F; Berchicci L; La Spina C; Battaglia Parodi M; Iacono P
    Ophthalmic Res; 2012; 48 Suppl 1():16-20. PubMed ID: 22907145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema.
    Moshfeghi DM; Kaiser PK; Michels S; Midena E; Kitchens JW; Prenner JL; Regillo CD; Reichel E
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6 Suppl):S4-S14. PubMed ID: 27348433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
    Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA;
    JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal Steroids in Diabetic Macular Edema.
    Lattanzio R; Cicinelli MV; Bandello F
    Dev Ophthalmol; 2017; 60():78-90. PubMed ID: 28427068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic macular edema: changing treatment paradigms.
    Arevalo JF
    Curr Opin Ophthalmol; 2014 Nov; 25(6):502-7. PubMed ID: 25211039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis.
    Avery RL; Gordon GM
    JAMA Ophthalmol; 2016 Jan; 134(1):21-9. PubMed ID: 26513684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
    Campochiaro PA; Peters KG
    Curr Diab Rep; 2016 Dec; 16(12):126. PubMed ID: 27778249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema.
    Puliafito CA; Cousins SW; Bacharach J; Gonzalez VH; Holekamp NM; Merrill PT; Ohr MP; Parrish RK; Riemann CD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Apr; 47(4 Suppl):S4-S15. PubMed ID: 27096289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.
    Evoy KE; Abel SR
    Ann Pharmacother; 2013 Jun; 47(6):811-8. PubMed ID: 23656749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological agents in development for diabetic macular edema.
    Sadiq MA; Halim MS; Hassan M; Onghanseng N; Karaca I; Agarwal A; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Int J Retina Vitreous; 2020; 6():29. PubMed ID: 32670612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.